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The altered metabolism of cancer can render cells dependent on the availability of metabolic
substrates for viability. Investigating the signaling mechanisms underlying cell death in cells
dependent upon glucose for survival, we demonstrate that glucose withdrawal rapidly induces
supra-physiological levels of phospho-tyrosine signaling, even in cells expressing constitutively
active tyrosine kinases. Using unbiased mass spectrometry-based phospho-proteomics, we show
that glucose withdrawal initiates a unique signature of phospho-tyrosine activation that is
associated with focal adhesions. Building upon this observation, we demonstrate that glucose
withdrawal activates a positive feedback loop involving generation of reactive oxygen species (ROS)
by NADPH oxidase andmitochondria, inhibition of protein tyrosine phosphatases by oxidation, and
increased tyrosine kinase signaling. In cells dependent on glucose for survival, glucosewithdrawal-
induced ROS generation and tyrosine kinase signaling synergize to amplify ROS levels, ultimately
resulting in ROS-mediated cell death. Taken together, these findings illustrate the systems-level
cross-talk between metabolism and signaling in the maintenance of cancer cell homeostasis.
Molecular Systems Biology 8: 589; published online 26 June 2012; doi:10.1038/msb.2012.20
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Introduction
Tumor cells exhibit an altered metabolism compared with non-
transformed cells, consuming glucose and glutamine and
producing lactate at prodigious rates. Building on Otto
Warburg’s initial observation of aerobic glycolysis in cancer
tissues (Warburg, 1956), tumorigenic metabolism is thought to
help satisfy the rapacious demands of highly proliferative
cancer cells for biosynthetic precursors including lipids,
proteins, and nucleic acids. In fact, the success of positron
emission tomography imaging for non-invasive imaging of
tumors using the radiolabeled glucose analog 18F-fluorodeoxy-
glucose relies upon the highly glycolytic tumor phenotype
(Czernin and Phelps, 2002).
Additional evidence has demonstrated that many oncogenic
kinases drive the high metabolic demands of cancer cells.
A prime example is the serine/threonine kinase Akt, which
increases aerobic glycolysis through upregulation of glucose
transporter levels and suppression of fatty acid b-oxidation
(Deberardinis et al, 2008). More recently, it was shown that
tyrosine kinases (TKs) including FGFR1 and a constitutively
active mutant of EGFR (EGFRvIII) can promote aerobic
glycolysis and lipogenesis, respectively (Guo et al, 2009;
Hitosugi et al, 2009).
One consequence of deregulated tumor metabolism is that
cells can become dependent on the supply of metabolic
substrates such as glucose or glutamine for viability (Elstrom
et al, 2004; Buzzai et al, 2005; Yuneva et al, 2007; Aykin-Burns
et al, 2009; Choo et al, 2010). Notably, this ‘addiction’ to
metabolic substrates is influenced by signal transduction
pathways. For example, expression of constitutively active
Akt renders glioblastoma (GBM) cells sensitive to glucose
withdrawal-mediated cell death (Elstrom et al, 2004). Alter-
natively, pharmacological activation or inhibition of kinases
involved in energy and nutrient sensing including AMPK
and mTORC1, respectively, can confer protection against
glucose withdrawal-mediated cell death (Buzzai et al, 2005;
Choo et al, 2010).
Molecular Systems Biology 8; Article number 589; doi:10.1038/msb.2012.20
Citation: Molecular Systems Biology 8:589
& 2012 EMBO and Macmillan Publishers Limited All rights reserved 1744-4292/12
www.molecularsystemsbiology.com
& 2012 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2012 1
Based on the evidence that oncogenic signaling can impose
a state of metabolic inflexibility, as well as the emerging
concept that complex networks link signal transduction with
metabolism (Wellen et al, 2010), we conducted a systems-level
investigation into the role of signal transduction underlying
cell death following metabolic perturbation in cell systems
dependent on glucose for survival. Using cell lines derived
from GBM, sarcoma, and melanoma, we report the unexpected
observation that glucose withdrawal induces supra-physiolo-
gical levels of phospho-tyrosine signaling in cells dependent
on glucose for viability. Using unbiased, mass spectrometry-
based phospho-tyrosine profiling, we discovered that glucose
withdrawal induces a unique phospho-tyrosine signature
associated with focal adhesions. Integrating this observation
with the literature describing the inhibition of protein tyrosine
phosphatases (PTPs) by NADPH oxidase (NOX)- and mito-
chondria-derived reactive oxygen species (ROS), we construct
a contextual systems model describing a positive feedback
loop involving ROS, PTPs, and TKs. Upon glucose deprivation,
this positive feedback loop results in synergistic amplification
of TK signaling and ROS levels, resulting in supra-physiologi-
cal levels of tyrosine phosphorylation and ROS-mediated cell
death. Taken together, our results describe a novel mechanism
integrating the metabolic and signaling systems homeostasis
of cancer cells.
Results
Glucose withdrawal induces supra-physiological
levels of phospho-tyrosine signaling in glucose
withdrawal-sensitive cells
To investigate the signaling mechanisms that underlie rapid
cell death following glucose withdrawal (i.e., glucose ‘addic-
tion’), we tested the response of four GBM cell lines (LN18,
LN229, T98, and U87MG) to withdrawal of glucose and the
glycolytic product pyruvate, which may serve as an alternate
substrate for the TCA cycle (Yang et al, 2009). Within 24 h of
glucose and pyruvate withdrawal, LN18, T98, and U87MG
exhibited rapid cell death, whereas LN229 cells exhibited only
a minor (B15%) loss of viability (Figure 1A), consistent with
previous reports (Elstrom et al, 2004). In our systems, standard
pyruvate levels (110 mg/l) did not rescue glucose starvation-
induced cell death (not shown). Using an antibody that
recognizes tyrosine phosphorylated proteins, western blotting
demonstrated that the glucose withdrawal-sensitive cell lines
(LN18, T98, and U87MG) exhibited a dramatic upregulation of
phospho-tyrosine signaling within 3–6 h of glucose starvation
(Figure 1B). In contrast, the glucose withdrawal-insensitive
cell line LN229 showed no induction of phospho-tyrosine
signaling. These data demonstrate that a severe metabolic
perturbation (i.e., glucose starvation) can induce supra-
physiological levels of TK signaling.
We next tested the specific requirements for cell death and
phospho-tyrosine induction. Serum factors did not modulate
cell death or the induction of phospho-tyrosine signaling
following glucose withdrawal (Supplementary Figure S1). In
addition, cells deprived of L-glutamine showed no decrease in
cell viability and only a very modest change in tyrosine
phosphorylation (Supplementary Figure S2). Comparing
glucose withdrawal-sensitive cell lines (LN18 and U87) to
the withdrawal-insensitive line LN229, we observed no
consistent changes in either phosphorylation of the AMPK
substrate pS79-acetyl coA carboxylase or stabilization of the
p53 tumor suppressor (data not shown). Thus, the phospho-
tyrosine induction and cell death observed following glucose
withdrawal are specific to the metabolic substrate glucose and
without evidence of AMPK signaling involvement.
To test whether the presence of a constitutively active TK
could affect the observed response to glucose withdrawal,
we next used U87 cells that overexpress a constitutively
active deletion mutant of EGFR found in B50% of GBMs
(variant III, U87-EGFRvIII) and exhibit constitutively high
levels of phospho-tyrosine signaling (Figure 1C; Wang et al,
2006). Expression of EGFRvIII did not alter the rate of
cell death compared with parental U87 cells (Figure 1D).
Surprisingly, even in the presence of the constitutively
active oncogenic kinase, glucose withdrawal induced
further upregulation of tyrosine phosphorylation, suggesting
that phospho-tyrosine induction is ligand independent
(Figure 1E). These data demonstrate that the rapid and
supra-physiological induction of TK signaling upon glucose
withdrawal can occur even in cells with high basal levels of
phospho-tyrosine signaling.
Next, we tested whether cells from cancers other than GBM
exhibit a similar response to glucose withdrawal. Cell lines
Figure 1 Glucose withdrawal induces supra-physiological levels of tyrosine phosphorylation in cells sensitive to glucose withdrawal. (A) LN18, LN229, T98, and U87
GBM cell lines were starved of glucose and pyruvate for 24 h. Trypan blue exclusion measurements demonstrated that LN18, T98, and U87, but not LN229, show a rapid
and complete loss of viability following glucose withdrawal. (B) Western blotting with a phospho-tyrosine antibody revealed that the glucose withdrawal-sensitive cell lines
(LN18, T98, and U87) exhibit a dramatic induction of phospho-tyrosine signaling at the indicated times following glucose withdrawal. Conversely, the glucose withdrawal-
insensitive cell line LN229 showed no increase in phospho-tyrosine levels following glucose withdrawal. Actin served as an equal loading control. (C–E) Glucose
withdrawal induces supra-physiological levels of phospho-tyrosine signaling even in cells expressing a constitutively active tyrosine kinase. (C) Expression of the
constitutively active EGFR mutant EGFRvIII in U87 cells induces high levels of phospho-tyrosine signaling as demonstrated by western blotting with an anti-phospho-
tyrosine antibody. (D) Expression of the constitutively active EGFRvIII mutant in U87 cells (U87-EGFRvIII) does not alter the sensitivity to glucose withdrawal at 24 h.
Error bars are standard deviation of the mean. (E) U87-EGFRvIII cells demonstrate a rapid induction of phospho-tyrosine signaling at the times indicated following
glucose withdrawal. For phospho-tyrosine, both dark and light film exposures are shown. (F–I) Human sarcoma- and melanoma-derived cell lines also demonstrate a
correlation between sensitivity to glucose withdrawal and rapid induction of supra-physiological phospho-tyrosine levels. (F) The sarcoma cell lines HT161 and TC32
were starved of glucose and pyruvate and their viability was measured by Trypan blue exclusion at the indicated times. TC32 cells show a rapid and complete loss of
viability, whereas HT161 were relatively insensitive to glucose withdrawal. Error bars are standard deviation of the mean. (G) Western blotting with an anti-phospho-
tyrosine antibody demonstrated that TC32, but not HT161, show induction of hyper-phosphorylation after 2 h of glucose starvation. (H) Melanoma cell lines M202, M207,
M229, and M249 were starved of glucose and pyruvate for 24 h. Trypan blue exclusion measurements revealed that M202 and M207, but not M229 or M249 cells,
showed significant loss of cell viability after 24 h of glucose withdrawal. Error bars are standard deviation of the mean. (I) Western blotting demonstrated that 7 h of
glucose withdrawal induced supra-physiological tyrosine phosphorylation in M202 and M207, but not M229 or M249.
Glucose deprivation activates a positive feedback loop
NA Graham et al
2 Molecular Systems Biology 2012 & 2012 EMBO and Macmillan Publishers Limited
derived from sarcoma patient biopsies exhibited a range of
sensitivities to glucose withdrawal (Figure 1F). Similarly to
GBM, the glucose withdrawal-sensitive cell line TC32 demon-
strated a dramatic and rapid induction of TK signaling,
whereas the glucose withdrawal-insensitive HT161 line
showed no increase (Figure 1G). Using cell lines derived from
melanoma patient biopsies, we again found a range of
sensitivities to glucose withdrawal (Figure 1H). Cells that were
sensitive to glucose withdrawal (M202, M207) demonstrated a
rapid induction in TK signaling, whereas glucose withdrawal-
insensitive cells did not (M229 and M249; Figure 1I). Notably,
the degree of glucose withdrawal-induced cell death was
not correlated with cell doubling time of the melanoma cell
lines (Supplementary Figure S3). Taken together, these data
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demonstrate a correlation between rapid cell death following
glucose withdrawal (i.e., glucose ‘addiction’) and a dramatic,
serum-independent induction of supra-physiological levels of
TK signaling.
PTEN status influences glucose withdrawal-
induced cell death and phospho-tyrosine
induction
Because the expression of constitutively active Akt can render
an insensitive GBM cell line (LN229) sensitive to glucose
withdrawal (Elstrom et al, 2004), we next tested whether
glucose withdrawal-induced TK signaling and induction of cell
death were regulated by PTEN, a negative regulator of Akt
signaling. To test this hypothesis, we expressed wild-type
murine Pten as well as two catalytically inactive mutants in
U87 cells, which are PTEN null and glucose withdrawal
sensitive. Wild-type Pten-overexpressing cells demonstrated
increased cell viability following glucose starvation
(Figure 2A), but two catalytically inactive mutants (C124S
and G129E) did not, demonstrating a requirement for the lipid
phosphatase activity of Pten for partial rescue from glucose
withdrawal. Furthermore, the increased resistance to glucose
withdrawal-induced cell death in U87-Pten was accompanied
by reduced phospho-tyrosine induction upon glucose with-
drawal (Figure 2B), providing further evidence for the
correlation between glucose withdrawal-induced phospho-
tyrosine signaling and cell death.
We next tested whether downregulation of endogenous
PTEN expression could similarly regulate the twin phenomena
of TK induction and cell death following glucose withdrawal.
We first tested HCT116 colon carcinoma cells with and without
homologous recombination-mediated deletion of endogenous
PTEN (Supplementary Figure S4). Cells lacking PTEN expres-
sion exhibited greater cell death and induction of phospho-
tyrosine signaling than parental wild-type cells (Figure 2C and
D). We next tested RWPE prostate epithelial cells with and
without shRNA-mediated knockdown of PTEN expression and
found that PTEN knockdown cells exhibited greater cell death
and greater phospho-tyrosine induction than parental cells
(Figure 2E and F). Notably, knockdown of PTEN expression
in an already glucose withdrawal-sensitive cell line (SF268)
did not further increase sensitivity to glucose withdrawal
(Supplementary Figure S5).
Taken together, these data demonstrate that PTEN, a
negative regulator of Akt signaling, can decrease sensitivity
to glucose withdrawal-induced TK induction and cell death.
However, it is clear that PTEN is not a master regulator of these
phenotypes, as demonstrated by the robust induction of
phospho-tyrosine signaling following glucose withdrawal
even in U87 cells overexpressing PTEN (Figure 2B).
Glucose withdrawal activates multiple TKs and
selected intracellular signaling pathways
Having established that PTEN influences but does not fully
control the sensitivity to glucose withdrawal, we sought to
gain a more detailed perspective on which TKs were activated
by glucose withdrawal. Using the glucose withdrawal-
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Figure 2 PTEN status regulates glucose withdrawal-induced phospho-tyrosine
induction and cell death. (A, B) Murine wild-type Pten or the lipid phosphatase
inactive mutants G129E and C142S were expressed in the PTEN-null GBM cell
line U87. (A) U87 cells infected with an empty vector control, wild-type Pten or the
lipid phosphatase inactive mutants were starved of glucose and pyruvate for 16
and 24 h, and viability was measured by Trypan blue exclusion. Expression of
wild-type Pten increased survival following glucose withdrawal by roughly two-
fold (P¼ 0.04 (*) and 0.001 (**) by Student’s t-test). Error bars are standard error
of the mean (n¼ 3). (B) Western blotting with an anti-phospho-tyrosine antibody
demonstrated that U87-Pten cells exhibit reduced induction of phospho-tyrosine
signaling after 3 h of glucose withdrawal. Pten and GRB2 served as confirmation
of Pten overexpression and equal loading, respectively. (C, D) HCT116 cells with
genetic knockout of PTEN show greater cell death and phospho-tyrosine
induction in response to glucose withdrawal. (C) HCT116 with wild-type PTEN
(WT) or genetic knockout by homologous recombination (HCT116-22, KO) were
serum starved for 16 h and then starved of glucose and pyruvate for 24 h before
measurement of viability by Trypan blue exclusion. PTEN knockout cells showed
reduced survival at 24 h compared with wild-type cells (P-value¼ 0.03 (*) by
Student’s t-test, n¼ 4). (D) Western blotting with an antibody against phospho-
tyrosine demonstrated increased phospho-tyrosine signaling in HCT116 PTEN
KO cells following 3 h of glucose withdrawal. Confirmation of loss of PTEN
expression in HCT116 KO cells is shown in Supplementary Figure S4. (E, F)
RWPE cells with reduced PTEN expression show greater cell death in response
to glucose withdrawal (P-value¼ 0.002 (*) by Student’s t-test, n¼ 3). (E) RWPE
cells with wild-type PTEN or cells infected with an shRNA targeting PTEN were
starved of glucose and pyruvate for 24 h before viability measurements by Trypan
blue exclusion. Confirmation of reduced PTEN expression is shown in
Supplementary Figure S4. (F) Western blotting demonstrated that RWPE cells
with reduced PTEN expression demonstrate greater induction of phospho-
tyrosine signaling following glucose withdrawal.
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sensitive cell lines U87 and U87-EGFRvIII, we found that
glucose withdrawal induced phosphorylation of EGFR on
residues Y1068, indicating enzymatic activation, and Y1045, a
docking site for c-Cbl (Figure 3A). The receptor TK (RTK) Met
also showed strong glucose withdrawal-induced phosphoryla-
tion of residues in the kinase activation loop (Y1234/Y1235)
and in the carboxy-terminal tail (Y1349). Additionally, we
found that phosphorylation of PDGFRb Y751, which regulates
enzymatic activation, was increased by glucose withdrawal.
Finally, we tested the non-RTK SRC and observed strong
glucose withdrawal-induced phosphorylation of the enzy-
matic activation site in the TK domain (Y416). Thus, these data
demonstrate that glucose withdrawal induces activation of
multiple receptor and non-RTKs.
We next asked which intracellular signaling pathways
downstream of RTKs were activated following glucose with-
drawal. Western blotting revealed activation of three MAPK
signaling pathways (ERK 1/2, JNK, and p38a) in both U87 and
U87-EGFRvIII cells (Figure 3B). In contrast, we found that
mTOR signaling, as measured by pS6 levels, and PI3K/Akt
signaling, as measured by pSer473-Akt levels, were unaffected
by glucose withdrawal. Because U87 and U87-EGFRvIII exhibit
high basal levels of mTOR and Akt signaling, it is possible that
these signaling pathways were saturated before glucose
withdrawal. Taken together, these data indicate that the
dramatic induction of supra-physiological levels of phospho-
tyrosine signaling caused by glucose withdrawal is accom-
panied by concomitant activation of some but not all
intracellular signaling pathways. This result led us to further
explore the spectrum of glucose withdrawal-induced signaling
using a more unbiased approach.
Phospho-proteomics reveals that glucose
withdrawal induces a distinct phospho-tyrosine
signature associated with focal adhesions
To obtain a more system-wide, unbiased characterization of
glucose withdrawal-induced phospho-tyrosine signaling,
we performed global and quantitative tyrosine phospho-
profiling using label-free quantitative mass spectrometry
(Skaggs et al, 2006; Rubbi et al, 2011). For both U87MG and
U87MG-EGFRvIII cells, we compared glucose deprivation
with three stimuli associated with activation of TK signaling:
(a) EGF, a ligand for EGFR, (b) vanadate, a chemical inhibitor
of PTPs, and (c) hydrogen peroxide (H2O2), a general
oxidative stress.
Phospho-tyrosine profiling of U87 and U87-EGFRvIII cells
identified 46 and 110 unique phosphorylation sites, respec-
tively. Hierarchical clustering of the data revealed patterns of
phospho-tyrosine peptide activation unique to all stimuli,
including the two strongest perturbations, vanadate treatment
and glucose withdrawal (Figure 3C; Supplementary Figure
S6A). Notably, these unique patterns of phospho-tyrosine
activation were preserved even when the data were normal-
ized to overall signal strength, indicating that the observed
signatures do not simply reflect increased activity of TKs (data
not shown). As expected, bioinformatic analysis revealed that
phospho-tyrosine sites activated by EGF stimulation were
enriched for proteins annotated with the EGFR signaling
pathway gene ontology term (Po0.001; Supplementary Figure
S6B). Despite the presence of highly activated EGFR
(Figure 3A), the EGF signaling pathway activation signature
was not recapitulated by glucose withdrawal (data not
shown). Instead, we noted the presence of highly phosphory-
lated focal adhesion-associated proteins in the glucose with-
drawal cluster (Figure 3D; Supplementary Figure S6C, n¼ 3 for
U87 and 8 for U87-EGFRvIII). Indeed, bioinformatic analysis
revealed that the glucose withdrawal phospho-tyrosine signa-
ture was highly enriched for peptides from focal adhesion
proteins (P¼ 0.015 and 0.004 for U87 and U87-EGFR-vIII,
respectively; Figure 3E; Supplementary Figure S6D). To
confirm this bioinformatic analysis, we tested whether glucose
deprivation induced activation of focal adhesion kinase (FAK)
and found that phosphorylation of the FAK activation site
(Y397) was increased by glucose deprivation in U87-EGFRvIII
(Figure 3F). Thus, unbiased phospho-proteomic profiling by
LC-MS/MS revealed that glucose deprivation induces phos-
pho-tyrosine signaling that is distinct from other phosphatase-
targeted perturbations and associated with focal adhesions
and activation of multiple TKs (e.g., EGFR, PDGFR, Met
and Src).
Glucose withdrawal induces ROS generation
in glucose withdrawal-sensitive cells
To determine how glucose withdrawal induces phospho-
tyrosine signaling in glucose withdrawal-sensitive but not in
insensitive cells, we tested the involvement of ROS that
mediate the differential response of cancerous cells and their
non-transformed counterparts to glucose withdrawal (Ahmad
et al, 2005; Aykin-Burns et al, 2009). In glucose withdrawal-
sensitive LN18 cells, we found that 3 h of glucose deprivation
induced a nearly two-fold increase in the mean fluorescent
intensity of the oxidation-dependent fluorogen DCF-DA
(Figure 4A). In contrast, LN229 cells, which are insensitive
to glucose withdrawal, demonstrated a negligible increase in
DCF-DA signal following glucose withdrawal (Figure 4B).
Similarly, we found that the glucose withdrawal-sensitive cell
lines T98 and U87 exhibited increased ROS levels following
glucose withdrawal, whereas the glucose withdrawal-insensi-
tive cell line M229 exhibited no change (Figure 4C;
Supplementary Figure S7A). Notably, increased ROS levels
occurred at times when cells could be rescued from glucose
withdrawal-induced cell death by resupplementation with
glucose and pyruvate (Supplementary Figure S7B). Treatment
with the H2O2 scavenger catalase abrogated the glucose
withdrawal-induced increase in DCF-DA signal in both LN18
and U87 cells (Supplementary Figure S7C).
Because mitochondria can contribute to oxidative stress
following glucose withdrawal (Ahmad et al, 2005), we next
tested whether levels of mitochondrial ROS were increased
following glucose withdrawal. Using the mitochondrial super-
oxide probe mitoSOX, we found that LN18 exhibited a roughly
two-fold increase in mitochondrial superoxide levels
(Figure 4D). In contrast, the glucose withdrawal-insensitive
cell line LN229 demonstrated negligible changes following
glucose withdrawal (Figure 4E). Similarly to DCF-DA,
we found that other glucose withdrawal-sensitive cell lines
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(e.g., T98 and U87) exhibited moderate to substantial
increases in mitochondrial superoxide levels upon glucose
and pyruvate starvation, whereas the glucose withdrawal-
insensitive cell line M229 showed little change (Figure 4F;
Supplementary Figure S7D). Taken together, these data
demonstrate that glucose withdrawal induces a rapid increase
in ROS in cells highly dependent on glucose for survival.
Glucose withdrawal-induced ROS mediate
TK induction and cell death
Having demonstrated that glucose withdrawal induces both
supra-physiological phospho-tyrosine signaling and increased
ROS levels in cells dependent on glucose for survival, we next
tested the functional relationship between TK signaling and
ROS induction upon glucose deprivation. In the glucose
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withdrawal-sensitive cell lines U87 and LN18, treatment with
the H2O2 scavenger catalase ablated the induction of phospho-
tyrosine signaling and activation of Src following glucose
withdrawal (Figure 5A). LN229 cells, which are insensitive to
glucose withdrawal, showed no change in either phospho-
tyrosine signaling or Src activation in the absence and
presence of catalase. Similarly to LN18, the sarcoma cell line
TC32 also demonstrated reduced glucose withdrawal-induced
phospho-tyrosine signaling when treated with catalase
(Supplementary Figure S8A). We next tested the effects of a
redox active manganic porphyrin (MnTMPyP) that can protect
cells against oxidative stress and found that glucose with-
drawal-induced activation of EGFRvIII phosphorylation was
strongly attenuated in U87-EGFRvIII cells by MnTMPyP
treatment (Figure 5B). These data indicate that ROS mediate
the induction of phospho-tyrosine signaling upon glucose
withdrawal.
Next, we tested whether ROS also mediate cell death upon
glucose withdrawal. In several glucose withdrawal-sensitive
GBM and sarcoma cell lines, treatment with the H2O2
scavenger catalase rescued cells from glucose withdrawal-
induced cell death (Figure 5C; Supplementary Figure S8D).
PEG-conjugated catalase, which can enter cells by endocy-
tosis (Beckman et al, 1988), also protected cells against
glucose withdrawal-induced cell death (data not shown).
Supporting this observation, treatment with either MnTMPyP
or cell-permeable reduced glutathione protected U87-EGFR-
vIII cells against glucose withdrawal-induced cell death
(Figure 5D; Supplementary Figure S8E). Taken together,
these data indicate that glucose withdrawal-induced ROS
are functionally required for rapid cell death following
glucose withdrawal.
NOX- and mitochondria-derived ROS contribute to
glucose withdrawal-induced phospho-tyrosine
signaling
Having demonstrated that ROS contribute to phospho-tyrosine
induction following glucose and pyruvate starvation, we next
sought to determine the cellular source(s) of ROS that mediate
glucose withdrawal-induced phospho-tyrosine signaling. We
first focused on NOX, a membrane bound protein complex that
generates superoxide anion because NOX is associated with
focal adhesions (Ushio-Fukai, 2006) and the glucose with-
drawal-induced phospho-tyrosine signature determined by
our phospho-tyrosine mass spectrometry experiments is
closely associated with focal adhesions (Figure 4). Treatment
with DPI, a chemical inhibitor of flavo-proteins including NOX,
completely abrogated glucose withdrawal-induced phospho-
tyrosine signaling in LN18, T98, and U87 cells (Figure 6A). To
confirm the role of NOX in glucose withdrawal-induced
phospho-tyrosine signaling, we next targeted the p22phox
organizer subunit that is required for the activity of NOX1–4
(Kawahara et al, 2005). Indeed, knockdown of p22phox
expression by siRNA attenuated glucose withdrawal-induced
phospho-tyrosine signaling (Figure 6B; Supplementary Figure
S9). Notably, siRNA targeting the Ca2þ -activated, p22phox-
independent NOX family members DUOX1, DUOX2, and NOX5
were unable to affect glucose withdrawal-induced phospho-
tyrosine signaling (Figure 6B and not shown). Thus, NOX-
derived ROS contribute to the rapid upregulation of phospho-
tyrosine signaling following glucose withdrawal in U87 cells.
Next, we sought to determine whether mitochondrial
superoxide also contribute to glucose withdrawal-induced
phospho-tyrosine signaling. Because intracellular calcium flux
has been linked to mitochondrial-mediated superoxide gen-
eration (Mbaya et al, 2010), we tested whether intracellular
Ca2þ contributes to glucose withdrawal-induced mitochon-
drial superoxide production. Indeed, treatment with the
cell permeable Ca2þ chelator BAPTA-AM reduced glucose
withdrawal-induced mitochondrial superoxide levels (Supple-
mentary Figure S10). Consistent with the hypothesis that
mitochondrial ROS mediate glucose withdrawal-induced
phospho-tyrosine signaling, treatment with BAPTA-AM but
not with extracellular EDTA substantially abrogated the
induction of phospho-tyrosine in the glucose withdrawal-
sensitive cell lines LN18, T98, and U87 (Figure 6C).
To more directly test the role of mitochondrial superoxide
generation in glucose withdrawal-induced phospho-tyrosine
signaling, we obtained or derived r0 sublines of T98 and
U87 GBM cells and the osteosarcoma line 143B.TK
(Supplementary Figure S11). Because several protein products
required for the mitochondrial electron transport chain are
Figure 3 Phospho-proteomics reveals that glucose withdrawal induces a distinct signature of phospho-tyrosine signaling that is associated with focal adhesions. (A, B)
Following glucose and pyruvate starvation of U87 and U87-EGFRvIII for the indicated times, western blotting revealed activation of some but not all signaling pathways
following glucose withdrawal. (A) Phospho-specific antibodies against tyrosine residues demonstrated significantly increased phosphorylation of RTKs, including EGFR,
Met, and PDFGRb. The non-RTK Src also showed increased active site phosphorylation. Total EGFR and actin served as equal loading controls. (B) Phospho-specific
antibodies revealed increased glucose withdrawal-induced activity of all MAPK pathways tested (ppERK 1/2, pJNK and p-p38a) but not mTOR signaling (pS235/S236-
S6) or Akt signaling (pS473-Akt). (C–E) Glucose withdrawal induces a signature of hyper-phosphorylation in U87 that is associated with focal adhesions. (C) Hierarchical
clustering of tyrosine phosphorylation in U87 cells reveals that glucose withdrawal induces a distinct set of phospho-events. U87 cells were treated with four stimuli
known to induce tyrosine phosphorylation, including (a) EGF stimulation (10 ng/ml, 5 min), (b) vanadate treatment (1 mM, 60 min), (c) H2O2 (5 mM, 30 min) and (d)
glucose and pyruvate withdrawal (3 h). Changes in phospho-tyrosine signaling were measured by quantitative, label-free mass spectrometry (Rubbi et al, 2011) and data
were hierarchically clustered. Each row of the heatmap depicts an individual phosphorylation event, and each column represents a sample as labeled. In the heatmap,
red and green represent normalized levels of high and low phosphorylation, respectively. Samples were measured in technical duplicate (r1 and r2). Branches of the
dendrogram associated with upregulation by glucose withdrawal and vanadate treatment are colored orange and blue, respectively. See Supplementary Table 1 for
quantitative phospho-peptide data. (D) Glucose withdrawal induces increased phosphorylation of proteins known to localize to focal adhesions. Tyrosine residues on
integrin b 1 (ITGB1 pY783), caveolin 1 (CAV1 pY14), and ephrin 2A (EPH2A pY588 and pY594) show dramatically increased phosphorylation in response to 3 h of
glucose withdrawal. (E) Phospho-events associated with focal adhesions are enriched following glucose withdrawal in U87 cells. Phospho-peptides were ranked
according to the measured log2 fold change in phospho-tyrosine levels following glucose withdrawal and plotted on a waterfall plot, where red and green represent
increased or decreased phosphorylation, respectively. Analysis of the phospho-peptides demonstrated an enrichment for proteins annotated with the GO term Focal
Adhesion (GO:0005925) at the top of the ranked list (i.e., increased phosphorylation following glucose withdrawal) (permutation-based P-value¼ 0.02). (F) Western
blotting revealed increased FAK Y397 phosphorylation in response to glucose withdrawal. Source data is available for this figure in the Supplementary Information.
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encoded on the mitochondrial genome, these r0 cells, which
lack mitochondrial DNA, are unable to generate mitochondrial
superoxide (Hashiguchi and Zhang-Akiyama, 2009). In all
three r0 derivatives, glucose withdrawal-induced phospho-
tyrosine signaling was absent (Figure 6D; Supplementary
Figure S11C). Glucose withdrawal did induce cell death in the
mitochondria-deficient U87 r0 and 143B.TK r0 cells, but this
death was not rescued by the H2O2 scavenger catalase
(Figure 6E). Together, these data demonstrate that the rapid
upregulation of phospho-tyrosine signaling following glucose
and pyruvate starvation involves both NOX- and mitochon-
dria-mediated ROS generation.
Glucose withdrawal-induced ROS oxidize and
inhibit PTPs
Because ROS are required for glucose withdrawal-induced
phospho-tyrosine signaling and ROS can inhibit PTPs by
oxidation of the catalytic cysteine residue (Lee et al, 1998a;
Meng et al, 2002), we hypothesized that supra-physiological
levels of phospho-tyrosine signaling following glucose with-
drawal were mediated by oxidative inhibition of PTPs. We first
measured total cellular PTP activity in U87 and LN229 cell
lysates using a phospho-substrate dephosphorylation assay.
Under standard culture conditions, lysates from both cell lines
had detectable levels of PTP activity. Following glucose
withdrawal, PTP activity of the glucose withdrawal-sensitive
cell line U87 was reduced by roughly two-fold whereas the PTP
activity of the insensitive cell line LN229 showed no change
(Figure 7A; Supplementary Figure S12A). Confirming that PTP
activity was inhibited by oxidation, the reducing agent DTT
rescued the PTP activity of U87 cell lysates following glucose
withdrawal.
To measure the effect of glucose withdrawal on a specific
PTP, we focused on PTP-1B because (a) PTP-1B can be
inhibited by oxidation of the catalytic cysteine (Lee et al,
1998a; Mahadev et al, 2001; Salmeen et al, 2003; Lou et al,
2008) and (b) our phospho-proteomic data revealed a 15-fold
increase in phosphorylation of PTP-1B Y20 following glucose
starvation (Supplementary Figure S12B). In both U87 and U87-
EGFRvIII cells, glucose withdrawal reduced PTP-1B activity by
roughly two-fold (Figure 7B). Confirming the functional
significance of glucose withdrawal-induced ROS, treatment
with the H2O2 scavenger catalase rescued PTP-1B activity.
Further confirming PTP-1B inhibitory oxidation, treatment of
immunoprecipitates with DTT also increased phosphatase
activity (data not shown). Taken together, these results show
that glucose withdrawal inhibits PTP activity through oxida-
tion by ROS.
Having established that glucose withdrawal-generated ROS
inhibit cellular PTP activity, we next tested whether chemical
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Figure 4 Glucose withdrawal induces rapid amplification of ROS in glucose withdrawal-sensitive cells. Cells were starved of glucose and pyruvate for 0 or 3 h, stained
with either the oxidation-sensitive fluorogen DCF-DA or mitoSOX, and analyzed by flow cytometry. (A, B) LN18 but not LN229 cells demonstrated increased DCF-DA
fluorescence 3 h following glucose and pyruvate starvation. (C) Quantification of the fold change in DCF-DA signal (3 h:0 h) revealed that the glucose withdrawal-
sensitive cell lines (LN18, T98, and U87) but not glucose withdrawal-insensitive cell lines (LN229 and M229) demonstrated increased ROS levels following glucose and
pyruvate withdrawal. Histograms for all cell lines are shown in Supplementary Figure S7. (D, E) LN18 but not LN229 cells demonstrated increased mitochondrial
superoxide production 3 h after glucose and pyruvate starvation. (F) Quantification of the fold change in mean mitoSOX signal (3 h:0 h) demonstrated that glucose
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inhibition of PTPs can induce ROS generation. Using the
general oxidation probe DCF-DA, we found that vanadate
treatment induced oxidative stress in LN18, T98, and U87 GBM
cell lines (Supplementary Figure S13). The observation of both
PTP inhibition-induced ROS and ROS-mediated PTP inhibition
suggested the existence of a positive feedback loop. We next
sought to determine if initiating this positive feedback loop
at two points would result in synergistic amplification. We
measured the viability of U87 cells after exposure to different
dose and time combinations of vanadate inhibition of PTPs
and glucose withdrawal (Figure 7C). We found that combina-
tions of vanadate treatment and glucose deprivation killed U87
cells more effectively than either treatment alone. Using the
method of Chou and Talalay (1984), we calculated that co-
treatment with glucose starvation and vanadate gave combi-
nation indices of less than one, indicative of positive synergy.
Plotting the linear additive isoboles further supported that
combinations of glucose starvation and vanadate exhibited
positive synergy (Figure 7D). These data demonstrate that
increased TK signaling can promote sensitivity to glucose
withdrawal, supporting the existence of a positive feedback
loop between glucose withdrawal-induced ROS generation,
PTP inhibition by ROS-mediated oxidation, increased TK
signaling, and further ROS generation.
Discussion
The reprogramming of cellular metabolism during oncogen-
esis has attracted considerable recent attention, even being
named one of the ‘emerging’ hallmarks of cancer (Hanahan
and Weinberg, 2011). The metabolic reprogramming that helps
satisfy the voracious appetite of tumor cells for biosynthetic
precursors can also render cells exquisitely sensitive to
nutrient deprivation (e.g., glucose and glutamine; Elstrom
et al, 2004; Yuneva et al, 2007; Aykin-Burns et al, 2009; Yang
et al, 2009). Here, we extend our understanding of this
phenomenon with the phospho-tyrosine proteomic-based
discovery that glucose deprivation provokes a systems-level
positive feedback loop between ROS generation, PTPs, and TK
signaling in cells dependent on glucose for survival (Figure 8).
Building on the unexpected observation that glucose with-
drawal induces supra-physiological levels of phospho-tyrosine
signaling, our systems-level feedback amplification loop
model integrates the observations that (a) glucose withdrawal
induces oxidative stress (Spitz et al, 2000; Aykin-Burns et al,
2009) and can activate diverse intracellular kinases including
ERK, JNK, and Lyn (Lee et al, 1998b, 2000; Blackburn et al,
1999), (b) focal adhesions and RTKs serve as sites of NOX-
mediated ROS generation (Lee et al, 1998a; Wu et al, 2005;
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withdrawal-induced phospho-tyrosine signaling was ablated by catalase treatment in U87 and LN18. In addition, glucose withdrawal-induced activation of the Src active
site (Y416) in LN18 cells required catalase-sensitive ROS. Actin served as an equal loading control. (B) U87-EGFRvIII cells were starved of glucose and pyruvate for 3 h
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(B155 kDa, the most prominent band in the phospho-tyrosine western blot) following glucose withdrawal. (C, D) ROS are required for cell death following glucose
withdrawal. (C) The glucose withdrawal-sensitive cell lines LN18, U87, and U87-EGFRvIII were starved of glucose and pyruvate with or without catalase, and viability
was measured by Trypan blue exclusion 24 h later. Catalase treatment rescued cells from glucose withdrawal-induced cell death (P-valueo1 10 3 (*) by Student’s
t-test). Error bars are standard deviation of the mean (n¼ 3–13). (D) U87-EGFRvIII cells were starved of glucose and pyruvate for 24 h in the absence or presence of the
antioxidant MnTMPyP. Treatment with MnTMPyP rescued U87-EGFRvIII from glucose withdrawal-induced cell death (P-value o1 10 3 (*) by Student’s t-test,
n¼ 13 and 3 for No treatment and MnTMPyP treatment, respectively).
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Diaz et al, 2009), and (c) ROS can inhibit PTPs, inducing
further TK signaling (Lee et al, 1998a; Mahadev et al, 2001;
Meng et al, 2002). Taken together, this systems perspective
reveals that glucose deprivation activates a positive feedback
amplification loop, as indicated by supra-physiological levels
of phospho-tyrosine signaling, until ROS accumulate above a
toxicity threshold resulting in cell death.
Notably, the systems-wide positive feedback loop described
here also functions in localized, subcellular contexts. A similar
feedback amplification loop involving signaling, ROS, and
PTPs occurs physically proximal to RTKs where EGF (Lee et al,
1998a) and insulin (Mahadev et al, 2001) induce oxidative
inhibition of PTP-1B to promote signaling. Related positive
feedback loops also occur at T-cell receptor signaling
complexes (Kwon et al, 2010) and focal complexes during
endothelial cell migration (Wu et al, 2005) and the formation
of invadopodia (Diaz et al, 2009). Here, we have demonstrated
that a metabolic perturbation (i.e., glucose withdrawal)
initiates a positive feedback amplification loop driven by
NOX- and mitochondria-derived ROS generation resulting
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Figure 6 NADPH oxidase- and mitochondria-derived ROS contribute to glucose withdrawal-induced phospho-tyrosine signaling. (A) Inhibition of NOX inhibits glucose
withdrawal-induced signaling. LN18, T98, and U87 cells were starved of glucose and pyruvate in the presence of DMSO or DPI (1 mM). Western blotting demonstrated
that NOX activity is required for the induction of phospho-tyrosine signaling. (B) Knockdown of the NOX subunit p22phox attenuates phospho-tyrosine signaling following
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were starved of glucose and pyruvate for 5 h. Western blotting demonstrated that knockdown of p22phox but not DUOX1/2 attenuated glucose withdrawal-induced
phospho-tyrosine signaling. p22phox knockdown efficiency was490% (Supplementary Figure S9). (C) LN18, T98, and U87 cells were starved of glucose and pyruvate in
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catalase (1 kU/ml), and viability was measured by Trypan blue exclusion 24 h later.
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in cell-wide consequences on phospho-tyrosine signaling
(Figure 3) and PTP activity (Figure 7), ultimately resulting in
cell death. In spatially localized contexts such as invadopodia
or T-cell receptor signaling complexes, positive feedback is
quickly dampened by reduction and re-activation of oxidized
PTPs. However, in the case of metabolic deficiency, cells are
unable to maintain redox homeostasis, perhaps due to
depletion of cellular pools of NADPH (Ahmad et al, 2005),
which drives the amplification of ROS until a cellular toxicity
threshold is breached and cells undergo ROS-mediated cell
death. Thus, the ROS-PTP-TK positive feedback amplification
loop set in motion by glucose withdrawal resembles positive
feedback loops that are quickly dampened under normal,
nutrient-rich conditions.
This work highlights the emerging concept of systems
integration between oncogenic signaling networks and
metabolism. For example, constitutively active oncogenic
kinases, including myristoylated Akt and the activated EGFR
mutant EGFRvIII, can promote aerobic glycolysis and lipo-
genesis, respectively (Elstrom et al, 2004; Guo et al, 2009).
Conversely, glucose metabolism can influence signaling, such
as the requirement of the hexosamine biosynthetic pathway
for signaling through IL3-RA (Wellen et al, 2010). Here, our
model demonstrates the bidirectional interactions between
signaling and metabolism. Our model predicts that either
reduced TK signaling or increased PTP activity at sites of ROS
generation (e.g., NOX complexes and mitochondria) should
protect cells from glucose withdrawal-induced cell death.
However, our data and model suggest that inhibition of a single
kinase or overexpression of a single PTP is likely insufficient to
rescue cells from glucose withdrawal-induced cell death
precisely because cell death is controlled by a systems-level
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Figure 7 Glucose withdrawal-induced ROS mediate oxidative inhibition of protein tyrosine phosphatases. (A) Glucose withdrawal causes oxidative inhibition of PTP
activity in glucose withdrawal-sensitive cells. U87 and LN229 cells were starved of glucose for 0 or 3 h, and the ability of cell lysates to dephosphorylate a phospho-
substrate was measured by quantitative western blotting. Addition of DTT to the dephosphorylation reaction reduced oxidized PTPs. Data were normalized to a
dephosphorylation reaction with the PTP inhibitor vanadate added (P¼ 0.04 (*) and 0.01 (**) by Student’s t-test (n¼ 3 for U87). A representative blot is shown in
Supplementary Figure S12A. (B) Glucose withdrawal inhibits PTP-1B activity by oxidation. U87 and U87-EGFRvIII cells were starved of glucose and pyruvate for 1.5 h
with or without catalase. PTP-1B was then immunoprecipitated from cell lysates under anaerobic conditions and incubated with the colorimetric phosphatase substrate
pNPP. PTP-1B activity was normalized to a no-antibody control and expressed in arbitrary units (AU). For both cell lines, glucose withdrawal reduced PTP-1B activity by
two-fold and catalase treatment rescued PTP-1B activity from the effects of glucose withdrawal (Po0.01 (*) and 0.02 (**) by combined Fisher’s method of paired
Student’s t-test for U87 and U87-EGFRvIII, n¼ 4 for U87, n¼ 8 for U87-EGFRvIII). (C) Glucose and pyruvate starvation and vanadate treatment synergistically kill U87
cells. U87 cells were exposed to increasing doses of vanadate for 1.5 h and then starved of glucose and pyruvate for the indicated times. The number of viable cells was
measured by Trypan blue exclusion 24 h later. To assess the degree of synergy, the combination index (Comb. Index) was calculated using the method of Chou and
Talalay (1984). Values less than one indicate positive synergy. Error bars are the standard deviation of the mean (n¼ 2). (D) Isobologram plot of the effect of glucose
and pyruvate starvation combined with vanadate treatment demonstrates positive synergy. The effective doses (ED) of glucose and pyruvate starvation (min) and
vanadate treatment (mM) are plotted on the x and y axis, respectively. Lines of linear additivity connect the ED for ED50, ED75, and ED100 for individual treatments.
Because the experimentally measured responses to combinations of glucose starvation and vanadate treatment (combination treatments) lie to the left of the linear lines
of additivity, glucose starvation and vanadate treatment interact with positive synergy. Source data is available for this figure in the Supplementary Information.
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positive feedback loop that simultaneously activates and
inhibits multiple TKs and PTPs, respectively. Indeed, over-
expression of PTEN, which functions as both a lipid and PTP
(Myers et al, 1997) and can undergo oxidative inactivation by
RTK-induced NOX1 activity (Kwon et al, 2004; Boivin et al,
2008), only partially dampened the positive feedback loop in
U87 cells (Figure 2). The diminished activity of PTPs following
glucose starvation (Figure 7) is also consistent with the
observation by us and others that serine/threonine MAPK
signaling is induced by glucose withdrawal (Figure 3B; Lee
et al, 1998b, 2000; Blackburn et al, 1999), as dual-specificity
phosphatases, which dephosphorylate MAPK enzymes, can be
inhibited by oxidation of the catalytic cysteine residue (Kamata
et al, 2005). Our observations thus add to the growing
evidence supporting the systems-level integration of metabo-
lism and signaling homeostasis.
The integrated nature of the ROS-PTP-TK positive feedback
loop described here offers an opportunity for therapeutic
intervention. Indeed, combinatorial activation of the ROS-PTP-
TK positive feedback loop with glucose deprivation and PTP
inhibition exhibited synergistic killing of U87 cells (Figure 7C
and D). Because many types of cancer cells exhibit increased
levels of ROS and weakened redox buffering compared with
normal cells (Szatrowski and Nathan, 1991; Toyokuni et al,
1995), ROS-promoting small molecule drugs can be selectively
toxic to cancer cells (Trachootham et al, 2006; Raj et al, 2011;
Shaw et al, 2011), Similarly, therapeutics targeting the
metabolic inflexibility of cancer are being pursued for selective
toxicity to tumor cells (Yuneva, 2008; Simons et al, 2009). Our
results highlight the possibility of unifying these two concepts
through the judicious selection of therapeutic cocktails
targeted against redox homeostasis and the metabolic inflex-
ibility of cancer.
In support of this hypothesis, combinations of the glycolytic
inhibitor 2-deoxyglucose and redox modulators (e.g.,
bulthione sulfoximine and antimycin A) demonstrate
enhanced cytotoxicity compared with either agent alone
(Andringa et al, 2006; Fath et al, 2009). Alternatively, it may
be possible to alter the redox balance of tumor cells using
physiological signals such as fasting, which can slow the
growth of tumor xenografts (Kalaany and Sabatini, 2009) and
enhance the efficacy of high-dose chemotherapy in mouse
models (Lee et al, 2012). In light of our data demonstrating that
glucose withdrawal-induced phospho-tyrosine signaling is
driven by focal adhesions, it is interesting to note that normal
epithelial cells exhibit loss of glucose transporters and
oxidative stress following detachment from extracellular
matrix (Schafer et al, 2009). Thus, the integrated nature of
metabolism, redox homeostasis, and signaling may permit
‘synthetic lethal’ therapeutic approaches with selective
toxicity toward tumor cells.
Finally, we speculate that this glucose withdrawal-initiated
positive feedback loop may regulate the survival of metabo-
lically altered tumor cells and/or select for metabolic
phenotypes in nutrient-limited environments in vivo. Recently,
it was demonstrated that low glucose media can select for
colorectal cancer cells with mutated KRAS and increased
GLUT1 expression (Yun et al, 2009). In a manner similar to the
hypoxic selection of cells with increased resistance to
apoptosis (Graeber et al, 1996), intermittent glucose depriva-
tion could select against cells dependent on glucose for
survival. Additionally, because hypoxia selects for cells with
increased glycolysis (Kim et al, 2007), it may be possible that
hypoxic and therefore glycolytic tumors are preferentially
sensitive to metabolic inhibition.
In summary, cellular redox homeostasis is maintained by
the balance between ROS generation by required metabolic
functions and ROS elimination. Likewise, signaling home-
ostasis is controlled by balancing kinase and phosphatase
activity. Here, we demonstrate that the cellular microenviron-
ment (i.e., nutrient availability) can alter the cellular redox
balance, provoking a signaling-based positive feedback loop
that amplifies ROS levels above a toxicity threshold resulting in
cell death. This positive feedback loop demonstrates the
complex, systems-level integration of homeostatic control
mechanisms for metabolism (e.g., redox balance) and TK
signaling (e.g., PTPs). Furthermore, this systems integration
offers a scaffold for synergistic combinations of therapeutics
targeting signaling, metabolism, and redox homeostasis.
Materials and methods
Cell culture
All cell lines were cultured in high-glucose DMEM (4.5 g/l glucose,
110 mM pyruvate; Mediatech) supplemented with 10% (v/v) FBS
(Omega Scientific) plus 1% (v/v) SPF (Invitrogen). For glucose
starvation, cells were washed twice with PBS and then incubated in
DMEM without glucose and pyruvate (0 g/l glucose, 0 mM pyruvate;
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Figure 8 Glucose withdrawal activates a positive feedback loop resulting in
supra-physiological phospho-tyrosine signaling and ROS-mediated cell death. In
cells dependent on glucose for survival, glucose and pyruvate deprivation
induces oxidative stress driven by NOX and mitochondria. This oxidative stress
provokes a positive feedback loop in which NOX and mitochondria generate
superoxide anion (O2
 ), which dismutes to hydrogen peroxide (H2O2) and inhibits
PTPs by oxidation (e.g., PTP-1B and PTEN). Without the negative regulation of
PTPs, TKs including EGFR and Src activate NOX at focal adhesions, further
amplifying ROS generation. This glucose withdrawal-induced positive feedback
loop results in supra-physiological levels of tyrosine phosphorylation and ROS-
mediated cell death.
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Invitrogen) supplemented with 10% dialyzed FBS (Omega Scientific)
plus 1% SPF. GBM cell lines LN18, LN229, T98, and U87 were
purchased from American Tissue Culture Collection (ATCC). U87-
EGFRvIII (Wang et al, 2006) and the melanoma cell lines M202, M207,
M229, and M249 (Nazarian et al, 2010; Sondergaard et al, 2010) have
been described previously. HT161 and TC32 sarcoma cell lines were
generously donated by Christopher Denny (UCLA). U87-Pten wild-
type, C124S, and G129E were constructed by amplification of murine
Pten constructs (Liliental et al, 2000) and cloning into the retroviral
backbone pDS-FB-hygro using Gateway technology (Invitrogen).
Stable overexpression of wild-type Pten and mutants was achieved
by retroviral transduction of U87 cells using retrovirus produced in
293T as described elsewhere (Rubbi et al, 2011) followed by selection
with hygromycin. HCT116 PTEN knockout cells were derived and
provided by T Waldman (Georgetown University). RWPE-1 and SF268
sublines with stable PTEN knockdown were generated by retroviral
transduction using a PTEN-targeted human specific shRNA (pSIREN-
RetroQ-PTEN; Vivanco et al, 2007). Viruses were generated by
transfecting the hairpin construct into an amphotropic packaging cell
line. Infected cells were selected with 3mg/ml puromycin. To generate
r0 cells lacking mitochondrial DNA, cells were cultured for 4–6 weeks
in media supplemented with dialyzed serum, 50 ng/ml ethidium
bromide, and 50 mg/ml uridine (Hashiguchi and Zhang-Akiyama,
2009). To confirm the loss of mitochondrial DNA, genomic and
mitochondrial DNA was harvested using a DNeasy kit (Qiagen), and
the presence of the mitochondrially encoded tRNA-Leu was assessed
by PCR (forward primer, 50-GATGGCAGAGCCCGGTAATCGC-30;
reverse primer, 50-TAAGCATTAGGAATGCCATTGCG-30). Presence of
the nuclear genome was confirmed by PCR against a region of the
X chromosome (forward primer, 50-GAAGGTGAAGGTCGGAGTC-30;
reverse primer, 50-GAAGATGGTGATGGGATTTC-30). To functionally
confirm the loss of the mitochondrial genome, r0 cells were tested for
uridine auxotrophy (Hashiguchi and Zhang-Akiyama, 2009).
Antibodies and reagents
Antibodies used for western blotting and immunoprecipitation
included: anti-phospho-tyrosine (clone 4G10) from Upstate;
anti-phospho-ERK1/2, anti-phospho-JNK, anti-phospho-p38alpha,
anti-phospho-S235/236-S6, anti-phospho-S473-Akt, anti-phospho-
Y1045-EGFR, anti-phospho-Y1068-EGFR, anti-total EGFR, anti-phos-
pho-Y1349 Met, anti-phospho-Y1234/Y1235-Met, anti-phospho-
751-PDGFRb, anti-phospho-Y416-SRC, and anti-phospho-Y397-FAK
from Cell Signaling Technology; anti-PTEN from Cascade Biosciences;
anti-total FAK from BD Biosciences; anti-total GRB2 and anti-total
PTP-1B from Santa Cruz Biotechnology. Catalase and pNPP were
purchased from Sigma. DPI, MnTMPyP, and glutathione monoethyl
ester (GSH-MEE) were from Calbiochem. CM-H2-DCF-DA and
mitoSOX were from Invitrogen.
Cell viability analysis
Viability was measured by Trypan blue exclusion using a Vi-Cell XR
2.03 viability analyzer (Becton-Dickinson) using optimized, cell type-
specific imaging parameters to distinguish live and dead cells.
Western blotting
Cells were lysed in modified RIPA buffer (50 mM Tris–HCl (pH 7.5),
150 NaCl, 10 mM b-glycerophosphate, 1% NP-40, 0.25% sodium
deoxycholate, 10 mM sodium pyrophosphate, 30 mM sodium fluoride,
1 mM EDTA, 1 mM vanadate, 20mg/ml aprotinin, 20 mg/ml leupeptin,
and 1 mM phenylmethylsulfonyl fluoride). Whole cell lysates were
resolved by SDS–PAGE on 4–15% gradient gels and blotted onto
nitrocellulose membranes (Bio-Rad). Membranes were blocked over-
night and then incubated sequentially with primary and either HRP-
conjugated (Pierce) or IRDye-conjugated secondary antibodies (Li-
Cor). Blots were imaged using either Amersham ECL Western Blotting
Detection Reagents (GE Healthcare) or the Odyssey Infrared Imaging
System (Li-Cor).
Flow cytometry
Cells were incubated with either 2.5mM CM-H2DCFDA or mitoSOX
(Invitrogen) for 30 min before analysis using a Becton Dickinson
FACScan analytic flow cytometer in the UCLA Jonsson Comprehensive
Cancer Center and Center for AIDS Research Flow Cytometry Core
Facility. Cells were gated using forward scatter and side scatter to
remove debris and dead cells, and 10 000 live cell events were recorded.
To quantify changes in DCF-DA or mitoSOX signal, mean fluorescent
intensity after gating was used.
Knockdown of p22phox subunit of NOX
siRNA constructs targeting p22phox (M-011020) and a non-targeting
control siRNA (D-001206) were purchased from Thermo Scientific.
Cells were reverse transfected with 30 pM siRNA. To assess knock-
down efficiency, total RNA was extracted using the RNeasy kit
(Qiagen) and reverse transcribed using the SuperScript VILO cDNA kit
(Invitrogen). The levels of p22phox cDNA were quantified by qPCR and
normalized to expression of GAPDH using the following primers:
p22phox forward 50-GGCGCTTCACCCAGTGGTACTTTGG-30 and reverse
50-TAGGTAGATGCCGCTCGCAATGGC-30; GAPDH forward 50-GAAGGT
GAAGGTCGGAGTC-30 and reverse 50-GAAGATGGTGATGGGATTTC-30.
Phospho-substrate dephosphorylation assay
Phospho-substrate was isolated via immunoprecipitation from U87-
EGFRvIII cells treated with vanadate (1mM) for 1 h. Cells were washed
with degassed PBS, snap frozen in liquid nitrogen, introduced into an
anaerobic chamber, lysed in dephosphorylation assay buffer (1% (v/v)
Triton X-100, 50 mM Tris (pH 7.5), 250 mM NaCl, 3 mM EDTA, 20mg/ml
aprotinin, 20mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride)
supplemented with ROS scavengers (250 U/ml catalase and 125 U/ml
superoxide dismutase; Calbiochem), and phospho-substrate (i.e.,
phospho-EGFRvIII) was immunoprecipitated from using a total EGFR
antibody. To test the effects of glucose starvation on PTP activity, U87
and LN229 cells were starved of glucose for 0 or 3 h and lysed in
dephosphorylation assay buffer as above. Endogenous EGFR was
immunodepleted from cell lysates, and the U87 or LN229 supernatant
was incubated with phospho-substrate for 30 min at 37oC in the
presence or absence of vanadate (1 mM) or DTT (2 mM). The remaining
phospho-substrate was assessed by quantitative western blotting and
normalized to total amount of substrate. Phosphatase activity was
normalized to the vanadate control and expressed as the fraction of
phosphorylation removed during the in vitro reaction.
Vanadate and glucose deprivation synergy assay
Cells were treated with increasing concentrations of vanadate for 90min
and then starved of glucose and pyruvate for 15–360 min. After
starvation, DMEM containing glucose and pyruvate was added back
to the cells. Twenty-four hours after the initial vanadate treatment, the
number of viable cells was quantified by Trypan blue staining on a
Vi-Cell XR 2.03 viability analyzer (Becton-Dickinson). To determine
synergistic, additive, or antagonistic effects of vanadate and glucose
deprivation, we used the combination index method of Chou and
Talalay (1984) using CalcuSyn (Biosoft). This method takes into account
both potency (median dose (Dm) or IC50) and the shape of the dose-effect
curve (the m value) to calculate the combination index (CI). A CI 41
indicates an antagonistic effect; a CIo1 indicates positive synergy.
PTP-1B phosphatase activity assay
PTP-1B activity was measured using a protocol modified from Pani
et al (2000). Following treatment, cells were washed once with
degassed PBS and snap frozen in liquid nitrogen. Cells were introduced
into an anaerobic hood supplemented with nitrogen and lysed in
degassed Triton-only lysis buffer without PTP inhibitors (1% (v/v)
Triton X-100, 50 mM Tris (pH 7.5), 150 mM NaCl, 10 mM sodium
pyrophosphate, 30 mM sodium fluoride, 2 mM EDTA, 20mg/ml
Glucose deprivation activates a positive feedback loop
NA Graham et al
& 2012 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2012 13
aprotinin, 20mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride)
supplemented with ROS scavengers (250 U/ml catalase and 125 U/ml
superoxide dismutase; Calbiochem). Equal amounts of total protein
were then immunoprecipitated with PTP-1B antibody under anaerobic
conditions at 4oC. Immunoprecipitates were incubated with 10 mM
p-nitrophenyl phosphate (Sigma) in HEPES buffer (62 mM HEPES
(pH 7), 6.25 mM EDTA) for 2 h at 37oC, quenched with NaOH,
and absorbance at 405 nm was measured. Data were normalized to a
control without PTP-1B antibody.
Quantitative, label-free phospho-tyrosine peptide
mass spectrometry
U87 and U87-EGFRvIII cells were grown, processed, and analyzed by
MS independently. Phospho-tyrosine peptide immunoprecipitation
was performed with a pan-specific anti-phospho-tyrosine antibody
(clone 4G10; Millipore) using 2108 cells (30 mg of total protein) as
previously described (Skaggs et al, 2006; Rubbi et al, 2011). Direct
quantitative comparison of our label-free approach with a label-based
approach (SILAC) showed high concordance in quantitation and
standard error (r¼ 0.95; Supplementary Figure S14 of Rubbi et al,
2011). Phosphorylated peptides were analyzed by LC-MS/MS with an
Eksigent autosampler coupled with a Nano2DLC pump (Eksigent) and
LTQ-Orbitrap (Thermo Fisher Scientific). The samples were loaded
onto an analytical column (10 cm, 75 mm inside diameter) packed with
5 mm Integrafit Proteopep2 300 A˚ C18 (New Objective). Peptides were
eluted into the mass spectrometer with a high-performance liquid
chromatography (HPLC) gradient of 5–40% buffer B in 45 min
followed by a gradient of 40–90% buffer B in 10 min, where buffer A
contained 0.1% formic acid in water and buffer B contained 0.1%
formic acid in acetonitrile. All HPLC solvents were Ultima Gold quality
(Fisher Scientific). Mass spectra were collected in positive ion mode
with the Orbitrap for parent mass determination and with the LTQ for
data-dependent MS/MS acquisition of the top five most abundant
peptides. Each sample was analyzed twice (technical duplicate runs).
MS/MS fragmentation spectra were searched with SEQUEST (Version
v.27, rev. 12; Thermo Fisher Scientific) against a database containing
the combined human-mouse International Protein Index (IPI) protein
database (downloaded December 2006 from ftp.ebi.ac.uk). Search
parameters included carbamidomethyl cysteine (*C) as a static
modification and phosphorylated tyrosine and oxidized methionine
(*M) as dynamic modifications. Results derived from database
searching were filtered using the following criteria: Xcorr 41.0
(þ 1), 1.5(þ 2), 2(þ 3); peptide probability scoreo0.001; DCn40.1;
and mass accuracy 25 p.p.m. with Bioworks version 3.2 (Thermo
Electron Corp.). Mass spectra have been deposited in the PRIDE
database (http://www.ebi.ac.uk/pride/, accession number
19835–19854).
We estimate the false-positive rate of sequence assignments at 0.5%
on the basis of a composite target-reversed decoy database search
strategy. Ascore was used to more accurately localize the phosphate on
the peptide (Beausoleil et al, 2006). As is common in data-dependent
MS2 fragmentation sequencing, some peptides identified by sequen-
cing in one sample may not be sequenced or identified in another
sample even if the peak is present. Peptide peaks sequenced in some
samples but not in others were located in the remaining samples by
aligning the chromatogram elution profiles by means of a dynamic
time warping algorithm (Prakash et al, 2006). An extended explana-
tion of the strategy used in this work, and example performance
results, can be found in the supporting information of Zimman et al
(2010) and Rubbi et al (2011). Relative amounts of the same phospho-
peptide across samples run together were determined with custom
software from our laboratory to integrate the area under the
unfragmented (MS1) monoisotopic peptide peak. All peaks corre-
sponding to phospho-sites discussed in the text were inspected
manually, and any errors in the automated quantitation were
corrected. Quantitative phospho-peptide values can be found in
Supplementary Tables S1 and S2.
The number of unique phosphorylation sites identified in our
experiments was determined by collapsing multiple phospho-peptide
ions representing the same phosphorylation site. Multiple detections
of the same phospho-site include phospho-peptides of different ion
charge state, modification (e.g., oxidized methionine), and misclea-
vage by trypsin. Multiple detections were compared with ensure no
disagreement in trend, and the MS ion with the highest intensity across
the samples was kept as representative for subsequent data analysis.
The residue numbers listed for phospho-sites correspond to the
indicated IPI accession number. Peptide quantities were unit normal-
ized and hierarchically clustered using the Pearson correlation in
Cluster 3.0 (Eisen et al, 1998).
Enrichment analysis for functional signaling
classes within phospho-tyrosine signatures
Phospho-tyrosine peptides were ranked by the log2-transformed fold
change observed for a given perturbation (e.g., glucose withdrawal
compared with untreated U87 cells). Peptides from proteins belonging
to a specified gene ontology term (e.g., Focal Adhesion GO:0005925)
were annotated using AMIGO (http://amigo.geneontology.org), and we
then calculated a Kolmogorov-Smirnov statistic against the expected
distribution. The statistical significance of enrichment was then
determined by permutation analysis. Briefly, permutation analysis
was performed by randomly shuffling the peptide ranked list, followed
by calculation of the Kolmogorov-Smirnov statistic for this permuta-
tion. After 1000 permutations, the fraction of randomly ranked lists
resulting in a Kolmogorov-Smirnov statistic greater than or equal to the
observed value was defined as the permutation-based frequency of
random occurrence (i.e., the permutation-based P-value).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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